EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)ÄquivalenzstudieMultizentrische StudieRandomisierte kontrollierte Studie

Combined Oral Ivermectin and 5% Permethrin Cream to Treat Severe Scabies

Charlotte Bernigaud, Giao Do-Pham, Elie Guichard, Marie Beylot-Barry, Elisa Goujon, Camille Isnard, Nathalie Beneton, Mahtab Samimi, Billal Tedbirt, Henri Adamski, Selma Azib, Emmanuel Mahé iD und 17 weitere

New England Journal of Medicine · 07.05.2026 · 394 (18) · 1814-1823

DOI: 10.1056/nejmoa2411721 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 07.05.2026. Verfasst von Charlotte Bernigaud und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hôpital Henri-Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP), Créteil, France. Hauptthemen laut MEDLINE: Antiparasitic Agents, Insecticides, Ivermectin, Permethrin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Ministère de la Santé, Société Française de Dermatologie et de Pathologie Sexuellement Transmissible, French Ministry of Health, Programme Hospitalier de Recherche Clinique.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Severe scabies, a rare parasitic skin disease characterized by abundant skin mites, may be life-threatening and poses public health concerns worldwide. A combination of standard-dose oral ivermectin and topical scabicides is recommended for treatment. However, data from randomized clinical trials are lacking, and the probability of cure is uncertain. Ivermectin at higher doses has been effective in the treatment of some parasitic diseases. METHODS: We conducted a blinded randomized trial involving adults with severe scabies (i.e., profuse or crusted), as confirmed by parasitologic or dermoscopic assessment. The patients were assigned in a 1:1 ratio to receive oral ivermectin (to be taken with food) at a dose of 400 μg per kilogram of body weight (higher-dose group) or 200 μg per kilogram (standard-dose group) on days 0, 7, and 14, combined with head-to-toe application of 5% permethrin cream on days 0 and 7 and daily application (as recommended) of an emollient cream. The primary end point was cure of severe scabies, which was defined as the absence of mites and mite-related products (i.e., eggs and feces), as confirmed by parasitologic or dermoscopic assessment on days 18 and 21, and the absence of active clinical lesions on physical examination on day 28. RESULTS: A total of 132 patients (66 in each group) were included in the main analysis. Cure was observed in 75% of the patients in the higher-dose group and in 82% of those in the standard-dose group (odds ratio for cure, 0.64; 95% confidence interval, 0.25 to 1.67). No safety issues were identified. CONCLUSIONS: Among adults, the 400-μg-per-kilogram dose of ivermectin plus 5% permethrin cream was not superior to the standard 200-μg-per-kilogram dose of ivermectin plus 5% permethrin cream in curing severe scabies. (Funded by the French Ministry of Health and French Society of Dermatology; ClinicalTrials.gov number, NCT02841215.).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiparasitic AgentsInsecticidesIvermectinPermethrinScabiesAdultAgedAnimalsFemaleHumansMaleMiddle AgedYoung AdultAdministration, OralDrug Therapy, CombinationSarcoptes scabieiSkin CreamAdministration, CutaneousDermoscopySkinSeverity of Illness IndexEmollientsDose-Response Relationship, DrugTreatment OutcomeAged, 80 and over

Substanzen

Antiparasitic AgentsInsecticidesIvermectinPermethrinEmollients

Autor:innen und Institutionen

  • Department of Dermatology, Hôpital Henri-Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP), Créteil, France.
  • Groupe Infectiologie et Infections Sexuellement Transmissibles (GrIDIST) of the French Society of Dermatology, Paris.
  • Department of Internal Medicine, Centre Hospitalier Intercommunal de Créteil, Créteil, France.
  • INSERM Centre d'Investigation Clinique (CIC) 1415, Centre Hospitalier Régional Universitaire (CHRU) de Tours, Tours, France.
  • Department of Dermatology, INSERM Unité 1312, Centre Hospitalier Universitaire (CHU) and Université de Bordeaux, Bordeaux, France.
  • Center of Evidence of the French Society of Dermatology, Paris.

ORCID-Profile: Emmanuel Mahé, Antoine Mahé, Sébastien Barbarot

Förderung

  • Ministère de la Santé
  • Société Française de Dermatologie et de Pathologie Sexuellement Transmissible
  • French Ministry of Health, Programme Hospitalier de Recherche Clinique

Zitieren

APA

Bernigaud, C., Do-Pham, G., Guichard, E., Beylot-Barry, M., Goujon, E., Isnard, C., Beneton, N., Samimi, M., Tedbirt, B., Adamski, H., Azib, S., Mahé, E., Michel, C., Perrot, J. L., Acquitter, M., Bursztejn, A. C., Chaby, G., Caux, F., Passeron, T., …, & Chosidow, O. (2026). Combined Oral Ivermectin and 5% Permethrin Cream to Treat Severe Scabies. New England Journal of Medicine, 394(18), 1814-1823. https://doi.org/10.1056/nejmoa2411721

Vancouver

Bernigaud C, Do-Pham G, Guichard E, Beylot-Barry M, Goujon E, Isnard C, et al. Combined Oral Ivermectin and 5% Permethrin Cream to Treat Severe Scabies. New England Journal of Medicine. 2026;394(18):1814-1823. doi:10.1056/nejmoa2411721

BibTeX
@article{Bernigaud2026,
  author = {Bernigaud, Charlotte and Do-Pham, Giao and Guichard, Elie and Beylot-Barry, Marie and Goujon, Elisa and Isnard, Camille and Beneton, Nathalie and Samimi, Mahtab and Tedbirt, Billal and Adamski, Henri and Azib, Selma and Mahé, Emmanuel and Michel, Catherine and Perrot, Jean-Luc and Acquitter, Marie and Bursztejn, Anne-Claire and Chaby, Guillaume and Caux, Frédéric and Passeron, Thierry and Vanhaecke, Clélia and Mahé, Antoine and Leccia, Marie-Thérèse and Barbarot, Sébastien and Lenormand, Cédric and Aubin, François and Foulet, Françoise and Grégoire, Laëtitia and Giraudeau, Bruno and Chosidow, Olivier},
  title = {Combined Oral Ivermectin and 5% Permethrin Cream to Treat Severe Scabies},
  journal = {New England Journal of Medicine},
  year = {2026},
  volume = {394},
  number = {18},
  pages = {1814--1823},
  doi = {10.1056/nejmoa2411721}
}
Kostenlos starten →